The effect of nebulized bronchodilator therapy on intraocular pressures in patients with glaucoma
L Kalra, MF Bone - Chest, 1988 - Elsevier
… greater than 21 mm Hg, peripheral or central visual field restriction, or optic disc changes at
… 10 and were at high risk of developing acute glaucoma, two had previous eye surgery, and …
… 10 and were at high risk of developing acute glaucoma, two had previous eye surgery, and …
Ocular hazards of nebulized bronchodilators
KM Mulpeter, JB Walsh, M O'Connor… - Postgraduate …, 1992 - academic.oup.com
… Summary: Three cases of pupiliary dilatation associated with the development of acute
glaucoma, precipitated by the use of nebulized bronchodilators are described. We suggest …
glaucoma, precipitated by the use of nebulized bronchodilators are described. We suggest …
[HTML][HTML] Ocular Surface, Intraocular Pressure, and Lens Condition in Bronchodilator and Steroid-Treated Patients with Chronic Pulmonary Disease
Ö Aydın Güçlü, A Sariyeva Ismayilov - Medical Principles and Practice, 2023 - karger.com
… In this study, we evaluated risk factors for dry eye disease, intraocular pressure, and …
bronchodilators or corticosteroids via nebulizer but not inhaler is related to greater rates of dry eye. …
bronchodilators or corticosteroids via nebulizer but not inhaler is related to greater rates of dry eye. …
Effect of nebulized ipratropium bromide on intraocular pressures in children
WTA Watson, EP Shuckett, AB Becker, FER Simons - Chest, 1994 - Elsevier
… It is not known if children are at risk for ocular complications from ipratropium bromide. We
hypothesized that nebulized ipratropium bromide… Ocular hazards of nebulized bronchodilators …
hypothesized that nebulized ipratropium bromide… Ocular hazards of nebulized bronchodilators …
Adverse Pulmonary Effects of Topical β Blockers Used in the Treatment of Glaucoma
… We found no significant risk of new use of bronchodilator … prior use of a xanthine or inhaled
steroid, we found a significant as… The data also point to the need to consider eye medications …
steroid, we found a significant as… The data also point to the need to consider eye medications …
Bronchodilator Nebulization–A Rare Presentation of Bilateral Acute Angle Closure Glaucoma
DD Syamala, M Medikonda - Delhi Journal of Ophthalmology, 2020 - journals.lww.com
… It is advisable that an ophthalmologist consultation is sought for patients deemed to be at
risk for AACG before initiating on bronchodilator therapy. This may be feasible in selected …
risk for AACG before initiating on bronchodilator therapy. This may be feasible in selected …
Clinical side effects during aerosol therapy: cutaneous and ocular effects
DE Geller - Journal of aerosol medicine, 2007 - liebertpub.com
… increased risks from … of inhaled bronchodilators causing acute elevation in ocular pressure.(6,7)
Small, prospective controlled studies have not found the same side effects from inhaled …
Small, prospective controlled studies have not found the same side effects from inhaled …
Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing
P Gupta, MS O'Mahony - Drugs & aging, 2008 - Springer
… Bronchodilators are used widely in patients with these conditions, but even when used in
inhaled form … [19] The challenge for physicians is to manage the risk of adverse drug reactions …
inhaled form … [19] The challenge for physicians is to manage the risk of adverse drug reactions …
Acute angle-closure glaucoma after albuterol nebulizer treatment
DS Rho - American journal of ophthalmology, 2000 - Elsevier
… tearing in the right eye after an albuterol nebulizer treatment, during which nebulized medication
had inadvertently entered her right eye. … Ocular hazards of nebulized bronchodilators …
had inadvertently entered her right eye. … Ocular hazards of nebulized bronchodilators …
Drug-induced ocular disorders
J Li, RC Tripathi, BJ Tripathi - Drug safety, 2008 - Springer
… associated visual field loss for which elevated intraocular pressure is one of the primary risk
… [17] Salbutamol is a β 2 -specific adrenergic agonist used as an inhalant for bronchodilation …
… [17] Salbutamol is a β 2 -specific adrenergic agonist used as an inhalant for bronchodilation …